Loading...
Antifungal properties of (2S, 4R)-Ketoconazole sulfonamide analogs
Blass, Benjamin E. Sharma, Rishabh Day, Brian M.
Blass, Benjamin E.
Sharma, Rishabh
Day, Brian M.
Citations
Altmetric:
Genre
Journal article
Date
2022-08-29
Advisor
Committee member
Department
Pharmaceutical Sciences
Permanent link to this record
Collections
Research Projects
Organizational Units
Journal Issue
DOI
http://dx.doi.org/10.3389/fddsv.2022.1000827
Abstract
Invasive candidiasis remains a significant health concern, as it is associated with a high mortality risk. In addition, the risk of infection is significantly elevated in immunocompromised patients such as those with HIV, cancer, or those taking imcmunosuppressive drugs as a result of organ transplantation. The majority of these cases are caused by C. albicans, and C. glabrata is the second most common cause. These infections are typically treated using approved antifungal agents, but the rise of drug-resistant fungi is a serious concern. As part of our on-going effort to identify novel antifungal agents, we have studied the in vitro antifungal properties of a series of sulfonamide analogs of (2S, 4R)-Ketoconazole. Herein we report on the in vitro activity against the key fungal pathogens C. albicans, and C. glabrata.
Description
Citation
Blass BE, Puri S, Sharma R and Day BM (2022) Antifungal properties of (2S, 4R)-Ketoconazole sulfonamide analogs. Front. Drug. Discov. 2:1000827. doi: 10.3389/fddsv.2022.1000827
Citation to related work
Frontiers Media
Has part
Frontiers in Drug Discovery
ADA compliance
For Americans with Disabilities Act (ADA) accommodation, including help with reading this content, please contact scholarshare@temple.edu